These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24789266)

  • 1. Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate.
    Sun NZ; Galvin J; Cooper KD
    JAMA Dermatol; 2014 Jul; 150(7):787-8. PubMed ID: 24789266
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous Rosai-Dorfman disease.
    Ohnishi A; Yoshida Y; Yamamoto O
    J Dermatol; 2008 Sep; 35(9):604-5. PubMed ID: 18837709
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide.
    Nadal M; Kervarrec T; Machet MC; Petrella T; Machet L
    Acta Derm Venereol; 2015 Jul; 95(6):758-9. PubMed ID: 25632986
    [No Abstract]   [Full Text] [Related]  

  • 4. Rosai-Dorfman disease treated with methotrexate and low-dose prednisone: case report and review of the literature.
    Nasseri E; Belisle A; Funaro D
    J Cutan Med Surg; 2012; 16(4):281-5. PubMed ID: 22784522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Rosai-Dorfman disease of the face with a leonine appearance: successful response to dapsone.
    Lee YI; Kim SK; Oh SH; Kim DY
    Eur J Dermatol; 2018 Apr; 28(2):255-256. PubMed ID: 29400286
    [No Abstract]   [Full Text] [Related]  

  • 6. Facial Cutaneous Rosai-Dorfman Disease.
    Flores-Terry MÁ; Romero-Aguilera G; González-López L; García-Arpa M
    Actas Dermosifiliogr; 2017 Jun; 108(5):480-482. PubMed ID: 28109522
    [No Abstract]   [Full Text] [Related]  

  • 7. Dermatoscopic findings in cutaneous Rosai-Dorfman disease and response to low-dose thalidomide.
    Wang F; Zhou H; Luo DQ; Han JD; Chen MK
    J Dtsch Dermatol Ges; 2014 Apr; 12(4):350-2. PubMed ID: 24580965
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose weekly methotrexate used to treat cutaneous Rosai-Dorfman disease.
    Subash JJ; Kesty C; Kesty KR; Asgari M; Jorizzo J
    Clin Exp Dermatol; 2018 Oct; 43(7):849-851. PubMed ID: 29869440
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic challenge of dapsone in the treatment of purely cutaneous Rosai-Dorfman disease.
    Chang HS; Son SJ; Cho KH; Lee JH
    Clin Exp Dermatol; 2011 Jun; 36(4):420-2. PubMed ID: 21564180
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment.
    Tjiu JW; Hsiao CH; Tsai TF
    Br J Dermatol; 2003 May; 148(5):1060-1. PubMed ID: 12786846
    [No Abstract]   [Full Text] [Related]  

  • 11. Intralesional methotrexate used in cutaneous Rosai-Dorfman disease.
    Nieto-Benito LM; Suárez-Fernández RM; Baniandrés-Rodríguez O
    Med Clin (Barc); 2020 Dec; 155(12):564-565. PubMed ID: 31759691
    [No Abstract]   [Full Text] [Related]  

  • 12. A case report demonstrating potential utility of topical imiquimod for cutaneous Rosai-Dorfman disease.
    Karadag AS; Tekin B; Hurdogan O; Dagdelen D; Dogan O; Buyukbabani N
    Dermatol Ther; 2019 Jan; 32(1):e12759. PubMed ID: 30288863
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous Rosai-Dorfman disease.
    Gaul M; Chang T
    Cutis; 2019 Mar; 103(3):171-173. PubMed ID: 31039225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of keratoacanthoma with intralesional methotrexate injections].
    Richard MA; Gachon J; Choux R; Laurans R; Folchetti G; Grob JJ
    Ann Dermatol Venereol; 2000 Dec; 127(12):1097. PubMed ID: 11173689
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of large cutaneous facial Rosai-Dorfman disease using combination of subtotal resection and ALA-PDT: A case report.
    Wan M; Ding A; Liu H; Ou J; Zhang J
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101879. PubMed ID: 32562733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of cutaneous Rosai-Dorfman disease to topical and intralesional steroids.
    Satter EK; Graham BS; Steger JW
    Br J Dermatol; 2003 Sep; 149(3):672-4. PubMed ID: 14511018
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide.
    Li X; Hong Y; An Q; Chen J; Wei H; Chen HD; Gao XH
    JAMA Dermatol; 2013 Aug; 149(8):992-3. PubMed ID: 23783880
    [No Abstract]   [Full Text] [Related]  

  • 18. Short course of infliximab for disfiguring lupus pernio.
    Kiorpelidou D; Gaitanis G; Zioga A; Bassukas ID
    Eur J Dermatol; 2008; 18(6):727-9. PubMed ID: 19049948
    [No Abstract]   [Full Text] [Related]  

  • 19. Fractional laser combined with 5-Aminolevulinic acid photodynamic therapy for the treatment of Cutaneous Rosai-Dorfman Disease: A case report.
    Wang H; Wang C; Wang X; Zhang L; Zhang M; Ge L; You Y
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103852. PubMed ID: 37858909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extranodal Rosai-Dorfman disease with cutaneous, ophthalmic and laryngeal involvement: report of a case treated with isotretinoin.
    Chang LY; Kuo TT; Chan HL
    Int J Dermatol; 2002 Dec; 41(12):888-91. PubMed ID: 12492979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.